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Type 2 diabetes mellitus (T2DM) is a major disease affecting nearly 280 million people worldwide. Whilst the pathophysio-
logical mechanisms leading to disease are poorly understood, dysfunction of the insulin-producing pancreatic beta-cells is
key event for disease development. Monitoring the gene expression profiles of pancreatic beta-cells under several genetic
or chemical perturbations has shed light on genes and pathways involved in T2DM. The EuroDia database has been
established to build a unique collection of gene expression measurements performed on beta-cells of three organisms,
namely human, mouse and rat. The Gene Expression Data Analysis Interface (GEDAI) has been developed to support this
database. The quality of each dataset is assessed by a series of quality control procedures to detect putative hybridization
outliers. The system integrates a web interface to several standard analysis functions from R/Bioconductor to identify
differentially expressed genes and pathways. It also allows the combination of multiple experiments performed on differ-
ent array platforms of the same technology. The design of this system enables each user to rapidly design a custom analysis
pipeline and thus produce their own list of genes and pathways. Raw and normalized data can be downloaded for each
experiment. The flexible engine of this database (GEDAI) is currently used to handle gene expression data from several
laboratory-run projects dealing with different organisms and platforms.
Database URL: http://eurodia.vital-it.ch
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Introduction
Glucose homeostasis is maintained through the efficient
modulation of insulin production and release by the pan-
creatic beta-cells coupled to a correct response of
insulin-sensitive cells to the hormone. Failure of the
beta-cells to produce adequate amounts of insulin triggers
progressive glucose intolerance and eventually overt type 2
diabetes mellitus (T2DM) (1). T2DM is a global public health
problem, affecting nearly 285 million individuals; preva-
lence of diabetes is projected to rise to 435 million
by 2030 (International Diabetes Federation, Diabetes
Atlas. Available at http://www.diabetesatlas.org/content/
diabetes-and-impaired-glucose-tolerance). This imposes a
huge burden on health-care systems. Of concern, the
pathophysiological mechanisms underlying beta cell failure
remain poorly understood, limiting the availability of novel
approaches to treat or prevent T2DM.
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.............................................................................................................................................................................................................................................................................................Monitoring the transcriptome of functional and dis-
turbed beta-cells might reveal genes and pathways
involved in the maintenance of normal beta-cell functional
capacity. In March 2006, a consortium of recognized
European experts in the field of T2DM initiated EuroDia,
an integrated project devoted to understanding the biol-
ogy of the pancreatic beta-cell. Several transcriptomics ex-
periments were planned using two different technologies,
custom spotted arrays and Affymetrix chips, on three or-
ganisms: human, mouse and rat. The EuroDia database has
been developed as a tool to integrate heterogeneous gene
expression datasets, to enable sharing of data and to pro-
vide efficient analysis methods to mine the information
content. Several public datasets from ArrayExpress (2),
NCBI Gene Expression Omnibus (3) and the BetaCell Gene
Bank (4,5) were first integrated into the system and, as the
project evolved, new unpublished experiments were added
and combined with public data for analysis. To stimulate
collaboration, once published in the database, these experi-
ments were shared freely between members of the
consortium.
At the time of publication, the EuroDia database con-
tains 38 curated experiments (441 hybridizations), 13 of
which were produced by members of the EuroDia project.
To ensure continuous access to this valuable data collection
after the formal end of the project, the EuroDia database
has now been opened to the whole T2DM research com-
munity for both consultation and contribution.
The Eurodia database has been built using Gene
Expression Data Analysis Interface (GEDAI), a flexible
framework for storing, analyzing and sharing gene expres-
sion data and results. GEDAI was originally developed for
EuroDia, and is currently being used as a gene expression
data storage and analysis pipeline for several other re-
search projects.
Data content
The EuroDia database is a web-accessible resource for stor-
ing and analyzing gene expression data from pancreatic
beta-cells. Raw and processed data files quantified from
individual hybridization scans are grouped into experi-
ments which are briefly described with a name, description,
type (one or more per experiment) and ownership.
Experiments are grouped into projects and are related to
an organism (human, mouse or rat) whose genome is anno-
tated with NCBI entrez gene data (6). Orthologous genes
are identified using the NCBI homologene id annotation
(6). These genome annotations enable comparisons be-
tween experiments studying either the same organism
but using different array designs, or experiments studying
different organisms. Additional annotations for the
Affymetrix mouse 430_2 array based on probe exon
mapping, signal intensity and uniqueness on the mouse
genome have also been included (7).
At the time of publication the EuroDia database contains
two projects, ‘EuroDia’ and ‘Public’. The Eurodia project
contains experiments performed by members of this
European consortium and the public project contains ex-
periments imported from public repositories. All EuroDia
experiments have both raw and normalized data available
(Table 1), whereas some of the public experiments have
only normalized data.
To upload an expression dataset, the user provides ex-
periment annotation in a predefined Microsoft Excel tem-
plate and uploads this file together with the raw data files
(CEL files for Affymetrix; GenPix, Imagene for spotted
arrays) zipped into an archive. Once uploaded, the raw
data are then normalized using RMA (8) for one color
arrays or loess (9) for two channel arrays and several quality
control plots are generated to assist the user in identifying
poor quality hybridizations.
Raw data can be downloaded either as binary
(Affymetrix) or text (spotted) files. Normalized data anno-
tated at the probe level with the manufacturer provided
annotations can be downloaded as text files. The quality
control graphs are arranged in a PDF report. Additionally,
both raw and processed data can be downloaded as a
Bioconductor (10) ExpressionSet object, which can be
easily loaded into an R session to perform analyses that
are not included in the EuroDia database.
The browse page of the EuroDia database (Figure 1) pro-
vides a convenient way to access an experiment. From this
page the user can visualize quality control graphs, down-
load data or perform statistical analysis for a dataset.
Experiments are grouped by experiment type (for example:
time series, dose response, compound treatment or genetic
variation), project, laboratory affiliation, organism or array
design, thus providing multiple entry points for a user to
access a particular experiment. Users can also find an ex-
periment by keyword using a search field.
Analysis tools
In addition to providing a data repository for a variety of
pancreatic beta-cell experiments, the EuroDia database
contains several analysis tools for mining the data.
Through the web interface, a user can identify differen-
tially expressed genes by fitting a linear model for each
gene and evaluating the fold change and moderated t-stat-
istics P-values (11). It is possible to use one of several web
forms designed to describe common experimental set-ups;
the different web forms available are for (i) group designs
allowing to compare two or more conditions, (ii) factorial
designs of type two by two for comparing the combined
effect of two conditions or treatments (e.g. the combined
effect of a treatment and a mutant background) or
.............................................................................................................................................................................................................................................................................................
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.............................................................................................................................................................................................................................................................................................Table 1. List of experiments contained in the EuroDia database
Name Group Technology References
Pancreatic islet implanted transgenic (expressing survivini) in mice Public Affymetrix
Beta cells (MIN6) treated with amylin at different times and doses and growth at
different concentrations of glucose
Public Affymetrix
Beta cell specific ablation of Foxa2 (HNF-3b) in mice Public Spotted
MIN6 cells treated with Exendin-4 over time Public Spotted
Pancreas versus islets Public Spotted
Transcription profiling of mouse islet growth after partial pancreatectomy and
exendin-4 treatment
Public Spotted
Mouse islets treated with PANcreatic DERived factor for 48 or 72h Public Spotted
Non-diabetic and diabetic obese mice—islets Public Affymetrix
HSL KO and WT Public Spotted
Tungstate-induced beta cell mass increase in STZ rats Public Affymetrix
Identification of tissue restricted and interferon alpha regulated transcripts in
human islet tissue
Public Affymetrix
LCM human islet beta cells Public Affymetrix
Nestin positive cells versus human islets Public Affymetrix
Pancreas versus islets Public Affymetrix
Human pancreatic islets from normal and type 2 diabetic subjects Public Affymetrix
Transcription profiling of HNF4 alpha null mice to investigate the phenotype of
dis-regulated insulin secretion and abnormal beta cell growth
Public Spotted
Cyclophosphamide-induced beta Cell Destruction in NOD Mice Public Affymetrix
PPAR gamma overexpression and activation in rat pancreatic islet Public Affymetrix
Pancreatic beta cell lines overexpressing wild-type MODY genes or mutant HNF1b
alleles
Public Affymetrix
Islet amyloid polypeptide effect on pancreatic cell line: time course and dose
responsed
Public Affymetrix
Transcription profiling of rat pancreatic islets after culture in low, intermediate
and high (glucose)
Public Affymetrix
Detailed transcriptome atlas of the pancreatic beta cell Public Affymetrix
GSIS Study of Rat INS1 cell lines Public Spotted
Lipotoxicity Study of Rat INS1 cell lines Public Spotted
foxA1 and beta cell function Public Spotted
Identification of novel cytokine induced genes in rat pancreatic beta-cells Eizirik Affymetrix (26)
Global profiling of double stranded RNA- and IFN-gamma-induced genes in rat
pancreatic beta cells
Eizirik Affymetrix (27)
Cytokine-induced and nuclear factor-kappa B-dependent genes in primary rat
beta-cells
Eizirik Affymetrix (28)
Global gene expression profiling in cytokine-treated rat pancreatic beta-cells Eizirik Affymetrix (29)
Global alternative splicing profiling in cytokine-treated rat pancreatic beta-cells Eizirik Affymetrix (29)
Gene expression differences between control and Tcf1/Hnf1alpha knock-out pan-
creatic islets
Ferrer Affymetrix (30)
Gene expression differences between control, Pancreas-specific Hnf4alpha
knock-out(P-Hnf4aKO, mediated by expression of Pdx-1Cre transgen),Tcf1/
Hnf1alpha heterozygous (Hnf1aHET) and double mutant (P-Hnf4a;Hnf1aHET)
pancreatic islets
Ferrer Affymetrix (31,32)
Gene expression data from murine islet samples comparing transgenic mice with
beta cell specific hormone sensitive lipase (HSL) overexpression with wild-type
mice
Holm Affymetrix
Calcineurin inhibitors on human islets Marchetti Affymetrix (33)
Type 2 diabetic versus non-diabetic islets Marchetti Affymetrix
(Continued)
.............................................................................................................................................................................................................................................................................................
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.............................................................................................................................................................................................................................................................................................(iii) paired samples where hybridizations are compared
by pairs. The latter may be used, for example, to identify
differentially expressed genes between alpha and beta
cells of six pancreas samples, each alpha cell sample being
paired with the beta cell sample from the same organ.
Radio buttons and checkboxes are used to assign each
hybridization to a condition. A few additional filters can
also be set to correct the obtained P-values for multiple
testing using either Holm, Benjamini-Hochberg or the
Storey-Tibshirani false discovery rate (FDR) methods
and to exclude probes showing low expression and/or
variance. Results are presented as tables that can
be sorted, filtered and downloaded together with
probe annotations provided by the array manufacturer
(Figure 2).
Once a set of differentially expressed genes has been
identified, the next step is often to explore the biology
around these genes. The EuroDia database provides several
tools to help extract valuable information and knowledge
from gene expression data. From the web interface a user
can evaluate whether the differentially expressed genes are
enriched for particular gene ontology (GO) (12) categories,
KEGG pathways (13) or Reactome metabolic maps (14).
The results are presented as a table of significant categories
Figure 1. Web interface. (A) Experiments can be grouped by type, laboratory affiliation, project, organism or array design. For
each category, experiment name and description are presented. Clicking on one experiment name reveals quality control plots
(B) and the list of related hybridizations. (C) For each hybridization, quality control plots are provided. (D) Experiments can be
downloaded in three forms: normalized data with probe annotation, raw data and Bioconductor expressionSet object.
Table 1. Continued
Name Group Technology References
Beta cells of type 2 diabetic subjects versus beta cells of non-diabetic controls Marchetti Affymetrix (34)
Islet S/A LF versus HF diet Schuit Affymetrix (35)
Islet WT versus islets S/A control diet Schuit Affymetrix (35)
HF-diet versus normal diet in islets of WT C57Bl6 mice Schuit Affymetrix
Time-course HFD study in WT mice Schuit Affymetrix
Double GIP-R+GLP1-R KO mice—pancreatic islets Thorens Spotted (36,37)
Comparison GLP-1 or GLP-1+diazoxide treatment of betaTcTet cells for 7h.
Pancreatic beta cell line
Thorens Spotted
Treatment of betaTcTet cells with GLP-1 (Glucagon-like peptide 1) for 0, 45min,
3h and 7h
Thorens Spotted (38)
Direct comparison of GLP-1 and GIP treatment for 7h on betaTcTet— Pancreatic
beta cell line
Thorens Spotted
HSL: hormone sensitive lipase, KO: knock-out, WT: wild-type, LCM: laser capture microdissection, GSIS: glucose stimulated insulin
secretion, S/A: eIF2-Ser51 is mutated to encode an alanine, LF: low fat, HF: high fat, HFD: high fat diet.
.............................................................................................................................................................................................................................................................................................
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In addition to these enrichment analyses, a user can also
perform Gene Set Enrichment Analysis (GSEA) (14) using
ordered gene lists to identify enriched pathways or
functionally related groups of genes. The gene lists for
GSEA can either be selected from MSigDB (14) or imported
by the user.
As an alternative, for some experiments a user might be
interested in identifying subgroups of genes and conditions
that share similar expression profiles (expression modules).
The EuroDia database interface offers the possibility to
identify expression modules using the iterative signature
algorithm (15–17). For each expression module, a GO cat-
egory, KEGG pathway and chromosomal location enrich-
ment is computed (18).
The EuroDia database contains datasets from different
organisms and different microarray platforms. It is possible
to combine multiple experiments of the same platform
type (Affymetrix or spotted) by merging probes using
either their unique probe identifier (to combine data
from two versions of the same platform), NCBI gene
index (to combine data from the same organism on differ-
ent platforms) or NCBI homologene id (to combine data
from different organisms). To address the problem of vari-
ability between measurements originating from different
laboratories, expression ratios between conditions are not
calculated for merged experiments. Instead, the rank prod-
ucts algorithm (20) is used to compare the co-occurrence of
one gene amongst the most up or down regulated genes of
all the compared hybridizations.
Finally, to provide a more global view of the data, tools
have been incorporated to display the expression profile of
a particular gene across the whole database and to meas-
ure the correlation of the global expression profiles of two
genes.
Implementation
The web interface of the EuroDia database is generated
using a combination of JavaScript and PHP scripts that
form the GEDAI framework. The data are stored in a
MySQL database. The majority of statistical analyses are
performed using packages from R/Bioconductor (10).
Quality controls and normalizations of two channel arrays
are performed with the marray (19) and limma (9) pack-
ages, and the affy (20) and affyPLM (8) packages are used
to process Affymetrix arrays. Affymetrix Gene and Exon
arrays are normalized using the Affymetrix Power Tools,
a set of command line programs from Affymetrix.
Normalized experiments are stored as Bioconductor
ExpressionSet objects that can be efficiently processed to
identify differentially expressed genes. These functions
are integrated in the limma (11), qvalue (21), RankProd
(22) and eisa (18) packages. GO categories and KEGG path-
ways enrichments are computed by functions of the
GOstats (23) package. The GSEA analysis is performed by
a speed-improved version of the original GSEA algorithm.
Most of the R scripts used to run analyses can be down-
loaded from the web interface.
Figure 2. Experiment analysis. The order of the boxes reflects the flow of analysis steps. From top to bottom and left to right,
the experiment name and description, the selection of the type of analysis, the form to describe analysis design (for this
example, paired samples design), the list of differentially expressed probes with their relevant gene symbol, expression ratios
and P-values of differential expression and the list of altered GO categories is provided.
.............................................................................................................................................................................................................................................................................................
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The EuroDia database is a unique collection of beta-cell
gene expression datasets generated by a consortium of
European experts. Relevant datasets have also been im-
ported from public repositories. Because of the need to
provide users in the different laboratories with a way of
uploading and sharing data that is both time-efficient
and user-friendly, we opted not to include all experimental
annotations that would be required to make the
database MIAME (24) compliant. However, by offering a
user-friendly interface to several well-accepted R/
Bioconductor packages, the EuroDia database enables to
rapidly evaluate the quality of a dataset, to identify differ-
entially expressed genes and to reveal potentially altered
biological pathways or molecular functions. Having the
data repository integrated with the analysis tools also
avoids the cumbersome steps of data extraction, reformat-
ting and loading of data into an external tool. A unique
feature of our database is its ability to combine studies
performed using different array platforms, or even differ-
ent organisms, in a single analysis. Other similar diabetes
resources such as T1DB (4,5) or EPConDB (25), whilst being
valuable data repositories, often lack the flexibility of
EuroDia, such as the integration of quality controls and
the ability to perform re-analysis.
The EuroDia database was built using the Gene
Expression Data Analysis Interface (GEDAI) framework,
which supports gene expression data measured with
Affymetrix gene chips, Agilent arrays, Illumina gene chips
and custom spotted arrays. Currently GEDAI is used for sev-
eral independent research projects and handles gene ex-
pression data from Arabidopsis, Ant, Mouse, Rat and
Human. The EuroDia database will be maintained in the
coming years and will evolve to integrate new gene expres-
sion datatypes like RNAseq. Scientists interested in deposit-
ing their array data are welcome to contact us at
eurodia@vital-it.ch.
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